m6A reader IGF2BP2-stabilized CASC9 accelerates glioblastoma aerobic glycolysis by enhancing HK2 mRNA stability
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
N 6-methyladenosine (m 6 A) has been identified to exert critical roles in human cancer; however, the regulation of m 6 A modification on glioblastoma multiforme (GBM) and long non-coding RNA (lncRNA) CASC9 (cancer susceptibility 9) is still unclear. Firstly, MeRIP-Seq revealed the m 6 A profile in the GBM. Moreover, the m 6 A-related lncRNA CASC9 expression was significantly elevated in the GBM tissue and its ectopic high expression was associated with poor survival, acting as an independent prognostic factor for GBM patients. Functionally, the aerobic glycolysis was promoted in the CASC9 overexpression transfection, which was inhibited in CASC9 knockdown in GBM cells. Mechanistically, m 6 A reader IGF2BP2 (insulin-like growth factor 2 mRNA binding protein 2) could recognize the m 6 A site of CASC9 and enhance its stability, then CASC9 cooperated with IGF2BP2, forming an IGF2BP2/CASC9 complex, to increase the HK2 (Hexokinase 2) mRNA stability. Our findings reveal that CASC9/IGF2BP2/HK2 axis promotes the aerobic glycolysis of GBM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In GBM, IMP2 recognizes the m6A modification site on the long non-coding RNA CASC9, enhancing its stability [13].”
From IMPlications of IMP2 in RNA Biology and Disease (2025) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“The upregulation of IMP2 in glioblastoma multiforme (GBM) is associated with poor prognosis.”
From IMPlications of IMP2 in RNA Biology and Disease (2025) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“The IMP2/CASC9 complex increases the ability of IMP2 to bind and stabilize HK2 mRNA, which in turn promotes glycolysis in GBM [13].”
From IMPlications of IMP2 in RNA Biology and Disease (2025) · cites this paper as [13]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“IMP3 directly bound the 3′-UTR of MEKK1 mRNA, stabilizing it and activating the MEK1/ERK signaling pathway, thereby promoting CRC malignancy.”
From IMPlications of IMP2 in RNA Biology and Disease (2025) · cites this paper as [13]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In cancer models, IMP3 KO mice demonstrated that IMP3 had a critical role in colorectal cancer (CRC) progression.”
From IMPlications of IMP2 in RNA Biology and Disease (2025) · cites this paper as [13]
Experimental — accuracy not yet measured
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Liu, X., Qin, J., Gao, T., Li, C., He, B., Pan, B., Xu, X., Chen, X., Zeng, K., Xu, M., et al. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.09.036 · Cited by 78
Self-citationRetractedZhang, S., Zhao, B. S., Zhou, A., Lin, K., Zheng, S., Lu, Z., Chen, Y., Sulman, E. P., Xie, K., Bögler, O., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.02.013 · Cited by 1,459
Self-citationFunctions of N6-methyladenosine and its role in cancer
He, L., Li, H., Wu, A., Peng, Y., Shu, G., & Yin, G. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1109-9 · Cited by 1,397
Wolf, A., Agnihotri, S., Micallef, J., Mukherjee, J., Sabha, N., Cairns, R., Hawkins, C., & Guha, A. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101470 · Cited by 789
Link Between m6A Modification and Cancers
Liu, Z.-X., Li, L.-M., Sun, H.-L., & Liu, S.-M. (2018) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2018.00089 · Cited by 373
Emerging treatment strategies for glioblastoma multiforme
Carlsson, S. K., Brothers, S. P., & Wahlestedt, C. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201302627 · Cited by 365
IGF2BP2 regulates DANCR by serving as an N6-methyladenosine reader
Hu, X., Peng, W.-X., Zhou, H., Jiang, J., Zhou, X., Huang, D., Mo, Y.-Y., & Yang, L. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-019-0461-z · Cited by 363
Metabolic Reprogramming in Glioma
Strickland, M., & Stoll, E. A. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00043 · Cited by 345
TP53 gain-of-function mutation promotes inflammation in glioblastoma
Ham, S. W., Jeon, H.-Y., Jin, X., Kim, E.-J., Kim, J.-K., Shin, Y. J., Lee, Y., Kim, S. H., Lee, S. Y., Seo, S., et al. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-018-0126-3 · Cited by 213
Biomarkers and therapeutic advances in glioblastoma multiforme
Sasmita, A. O., Wong, Y. P., & Ling, A. P. K. (2017) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.12756 · Cited by 184
Cited by
m6A-regulated tumor glycolysis: new advances in epigenetics and metabolism
Yue, S., Liu, H., Su, H.-F., Luo, C., Liang, H., Zhang, B., & Zhang, W. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01841-8 · Cited by 140
“The complex can also bind to the methylation site on HK2 mRNA to improve the stability of HK2 mRNA and promote GBM glycolysis [157].”
BackgroundSelf-citationThe role of Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs) as m6A readers in cancer
Sun, C., Cao, D., Du, B.-B., Chen, C., & Liu, D. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.70458 · Cited by 109
Liu, Z., Gao, L., Cheng, L., Lv, G., Sun, B., Wang, G., & Tang, Q. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-00944-y · Cited by 100
Zhong, C., Long, Z., Yang, T., Wang, S., Zhong, W., Hu, F., Teoh, J. Y., Lü, J., & Mao, X. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.77133 · Cited by 65
“Moreover, some specific m6A readers, such as IGF2BP2, could interact with circRNA to enhance its stability [34, 35].”
BackgroundZheng, H., Zhu, M., Li, W., Zhou, Z., & Wan, X. (2022) · Liver International · doi:10.1111/liv.15240 · Cited by 59
Metadata
- Authors
- Liu, H., Qin, S., Liu, C., Jiang, L., Li, C., Yang, J., Zhang, S., Yan, Z., Liu, X., Yang, J., & Sun, X.
- Affiliations
- Second Hospital of Hebei Medical University (CN)
- Hebei Medical University (CN)
- Corresponding author
- Sun, Xiaofeng
- Venue
- Cell Death Discovery
- Published
- 2021-10-13
- Volume
- 7
- Issue
- 1
- Pages
- 292-292
- ISSN
- 2058-7716 (ISSN-L)
- PMC
- PMC8514511
- OpenAlex
- W3205577640
- Cited by
- 58
- References
- 21
- Citations by year
- 2026: 10 · 2025: 10 · 2024: 17 · 2023: 10 · 2022: 11
- FWCI
- 3.45
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Cell Death Discovery (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- China Aerospace Science and Technology Corporation
- Fondo para la Investigación Científica y Tecnológica (QN2018020)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA modifications and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- glioblastoma, N6-methyladenosine, m6A reader, IGF2BP2, CASC9, long non-coding RNA, HK2, aerobic glycolysis, mRNA stability, prognostic factors, cancer metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: m6A reader IGF2BP2-stabilized CASC9 accelerates glioblastoma aerobic glycolysis by enhancing HK2 mRNA stability. https://app.cochat.ai/papers/10.1038/s41420-021-00674-y
- The paper
- Liu, H., Qin, S., Liu, C., Jiang, L., Li, C., Yang, J., Zhang, S., Yan, Z., Liu, X., Yang, J., & Sun, X. (2021). m6A reader IGF2BP2-stabilized CASC9 accelerates glioblastoma aerobic glycolysis by enhancing HK2 mRNA stability. Cell Death Discovery. https://doi.org/10.1038/s41420-021-00674-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.